Diagnosis-Specific Management of Somatoform Disorders: Moving Beyond "Vague Complaints of Pain"

Journal of Pain

Volumn 10, Issue 11, 2009, Pages 1128-1137

  Dohrenwend, Anne ^a   Skillings, Jared Lyon ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

medically unexplained symptoms; pain management; pain patient; primary care; somatization; Somatoform disorders

Indexed keywords

ARTICLE; BODY DYSMORPHIC DISORDER; CONVERSION DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; FACTITIOUS DISEASE; HUMAN; HYPOCHONDRIASIS; PAIN; PATIENT CARE; PERSONALITY DISORDER; SOMATOFORM DISORDER; TREATMENT PLANNING;

DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; PAIN; PSYCHOLOGICAL TESTS; SOMATOFORM DISORDERS;

EID: 70350568095     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2009.04.004     Document Type: Article

References (61)

1. Abbey S. Somatization and somatoform disorders. In: Levenson J. (Ed) (2005), The American Psychiatric Publishing Textbook of Psychosomatic Medicine. Washington, DC 271-296
2. Adler R., Zamboni P., Hofer T., and Hemmeler W. How not to miss a somatic needle in a haystack of chronic pain. J Psychosom Res 42 (1997) 499-505
3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th edition, Text Revision (DSM-IV-TR). Washington, DC, APA, 2000
4. Arnold B., Alpers G., Süss H., Friedel E., Kosmützky G., Geier A., and Pauli P. Affective pain modulation in fibromyalgia, somatoform pain disorder, back pain, and healthy controls. Eur J Pain 12 (2008) 329-338
5. Barsky A., and Ahern D. Cognitive behavioral therapy for hypochondriasis: A randomized controlled trial. JAMA 291 (2004) 1464-1470
6. Barsky A., Fama J., Bailey E., and Ahern D. A prospective 4- to 5- year study of DSM-III-R hypochondriasis. Arch Gen Psychiatry 55 (1998) 737-744
7. Barsky A., Orav E., and Bates D. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 62 (2005) 903-910
8. Barskey A., and Wyshak G. Hypochondriasis and somatosensory amplification. Br J Psychiatry 157 (1990) 404-409
9. Bienvenu O., Samuels J., Riddle M., Hoehn-Saric R., Liang K., Cullen B., Grados M., and Nestadt G. The relationship of obsessive-compulsive disorder to possible spectrum disorders: Results from a family study. Biol Psychiatry 48 (2000) 287-293
10. Bohne A., Keuthen N., Wilheim S., Deckersback T., and Jenike M. Prevalence of symptoms of body dysmorphic disorder and its correlates: A cross-cultural comparison. Psychosomatics 43 (2002) 486-490
11. Butcher J. Minnesota Multiphasic Personality Inventory-2, User's Guide, the Minnesota Report: Adult Clinical System (1989), National Computer Systems, Minneapolis, MN
12. Creed F., and Barsky A. A systematic review of the epidemiology of somatisation disorder and hypochondriasis. J Psychosom Res 56 (2004) 391-408
13. deWaal M., Arnold I., Eekhof J., and van Hemert A. Somatoform disorders in general practice: Prevalence, functional impairment with comorbidity with anxiety and depressive disorders. Br J Psychiatry 184 (2004) 470-476
14. Eifert G., and Zvolensky M. Somatoform disorders. In: Winstead B., and Maddux J. (Eds). Psychopathology: Foundations for a Contemporary Understanding (2005), Lawrence Erlbaum Associates, Mahwah, NJ 281-300
15. Eisen J., Phillips K., Coles M., and Rasmussen S. Insight in obsessive compulsive disorder and body dysmorphic disorder. Compr Psychiatry 45 (2004) 10-15
16. Epstein R., Quill T., and McWhinney I. Somatization reconsidered: Incorporating the patient's experience of illness. Arch Intern Med 159 (1999) 215-222
17. Fackler S., Anfinson T., and Rand J. Serial sodium amytal interviews in the clinical setting. Psychosomatics 38 (1997) 558
18. Fink P., Hansen M., and Oxhoj M.-L. The prevalence of somatoform disorders among internal medical patients. J Psychosom Res 56 (2004) 413-418
19. Fishbain D. Polypharmacy treatment approaches to the psychiatric and somatic comorbidities found in patients with chronic pain. Am J Phys Med Rehabil 84 (2005) S56-S63
20. Fishbain D. Approaches to treatment decisions for psychiatric comorbidity in the management of the chronic pain patient. Med Clin North Am 83 (1999) 737-760
21. Ford C. Deception syndromes: Factitious disorders and malingering. In: Levenson J. (Ed). The American Psychiatric Publishing Textbook of Psychosomatic Medicine (2005), American Psychiatric Publishing, Washington, DC 297-309
22. Guggenheim F. Somatoform disorders. In: Sadock B., and Sadock V. (Eds). Comprehensive Textbook of Psychiatry. 7th Edition (2000), Williams & Wilkins, Philadelphia, Lippincott 1504-1532
23. Guggenheim F., and Smith G. Somatoform Disorders. In: Kaplan H., and Sadock B. (Eds). Comprehensive Textbook of Psychiatry. 6th ed (1995), Williams, & Wilkins, Baltimore 1251-1270
24. Hahn S., Thompson K., Wills T., Stern V., and Budner N. The difficult doctor-patient relationship: Somatization, personality and psychopathology. J Clin Epidemiol 47 (1994) 647-657
25. Hellman C., Budd M., Borysenko J., McClelland D., and Benson H. A study of the effectiveness of two group behavioral medicine interventions for patients with psychosomatic complaints. Behav Med 8 (1990) 165-173
26. Henningsen P., Jakobsen T., Schiltenwolf M., and Weiss M. Somatization revisited: Diagnosis and perceived causes of common mental disorders. J Nerv Ment Dis 193 (2005) 85-92
27. Jacobi F., Wittchen H., Hölting C., Höfler M., Pfister H., Müller N., and Lieb R. Prevalence, co-morbidity and correlates of mental disorders in the general population: Results from the German Health Interview and Examination Survey (GHS). Psychol Med 34 (2004) 597-611
28. Keeley R., Smith M., and Miller J. Somatoform symptoms and treatment nonadherence in depressed family medicine outpatients. Arch Fam Med 9 (2000) 46-54
29. Kirmayer L., Robbins J., and Paris J. Somatoform disorders: Personality and the social matrix of somatic distress. J Abnorm Psychol 103 (1994) 125-136
30. Krahn L., Hongzhe L., and O'Connor M. Patients who strive to be ill: Factitious disorder with physical symptoms. Am J Psychiatry 160 (2003) 1163-1168
31. Kroenke K., Arrington M.E., and Mangelsdorff A.D. The prevalence of symptoms in medical outpatients and the adequacy of therapy. Arch Intern Med 150 (1990) 1685-1689
32. Kroenke K., and Price R. Symptoms in the community: Prevalence, classification, and psychiatric comorbidity. Arch Intern Med 153 (1993) 2474-2480
33. Kroenke K., Sharp M., and Sykes R. Revising the classification of somatoform disorders: Key questions and preliminary recommendations. Psychosomatics 48 (2007) 277-285
34. Kroenke K., and Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: A critical review of controlled clinical trials. Psychother Psychosom 69 (2000) 205-215
35. Lazare A. Conversion symptoms. N Engl J Med 305 (1981) 745
36. Leichsenring F., and Leibing E. The effectiveness of psychodynamic therapy and cognitive behavior therapy in the treatment of personality disorders: A meta-analysis. Am J Psychiatry 160 (2003) 1223-1232
37. Lidbeck J. Group therapy for somatization disorders in general practice: Effectiveness of a short cognitive-behavioral treatment model. Acta Psychiatr Scand 96 (1997) 14-24
38. Lipowski Z. Somatization: The concept and its clinical application. Am J Psychiatry 145 (1988) 1358-1368
39. Manchikanti L., Giordano J., Boswell M., Fellows B., Manchukonda R., and Pampati V. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manag 3 (2007) 89-100
40. Mayou R., Kirmayer L., Simon G., Kroenke K., and Sharpe M. Somatoform disorders: Time for a new approach in DSM-V. Am J Psychiatry 162 (2005) 847-855
41. Miller M. What is body dysmorphic disorder?. Harvard Mental Health Letter (July 1, 2005)
42. Millon T., Antoni M., Millon C., Meagher S., and Grossman S. Millon Behavioral Medicine Diagnostic Manual (2001), NCS Pearson, Inc, Minneapolis, MN
43. Moss-Morris R., Humphrey K., Johnson M., and Petrie K. Patients' Perceptions of Their Pain Condition Across a Multidisciplinary Pain Management Program: Do They Change and If So Does It Matter?. Clin J Pain 23 (2007) 558-564
44. Neziroglu F., McKay D., Todaro J., and Yaryura-Tobias J. Effect of cognitive behavior therapy on persons with body dysmorphic disorder and comorbid Axis II diagnoses. Behav Ther 27 (1996) 67-77
45. Ovsiew F. Hysteria in neurological practice: The somatoform and dissociative disorders. In: Jeste D., and Friedman J. (Eds). Psychiatry for Neurologists (2006), Humana Press, Totowa, NJ 67-80
46. Perugi G., Akiskal H., Giannotti D., Frare F., DiVaio S., and Cassano G. Gender-related differences in body dysmorphic disorder (dysmorphophobia). J Nerv Ment Dis 185 (1997) 578-582
47. Phillips K., McElroy S., Dwight M., Eisen J., and Rasmussen S. Delusionality and response to open-label fluvoxamine in body dysmorphic disorder. J Clin Psychiatry 62 (2001) 87-91
48. Phillips K.A., and Menard W. Suicidality in body dysmorphic disorder: A prospective study. Am J Psychiatry 163 (2006) 1280-1282
49. Reich P., and Gottfried L. Factitious disorders in a teaching hospital. Ann Intern Med 99 (1983) 240-247
50. Sansone R., Wiederman M., and Sansone L. Medically self-harming behavior and its relationship to borderline personality symptoms and somatic preoccupation among internal medicine patients. J Nerv Ment Dis 188 (2000) 45-47
51. Sharpe M. Cognitive behavioral therapies in the treatment of functional somatic symptoms. In: Mayou R., Bass C., and Sharpe M. (Eds). Treatment of functional somatic syndromes (1995), Oxford University Press, Oxford, England 122-143
52. Smith R. Somatization disorder: Defining its role in clinical medicine. J Gen Intern Med 6 (1991) 168-175
53. Smith G.C., Clarke D.M., Handrinos D., and McKenzie D.P. Consultation-liaison psychiatrists' management of somatoform disorders. Psychosomatics 41 (2000) 481-489
54. Smith R., Gardiner J., Lyles J., Sirbu C., Dwamena F., Hodges A., Collins C., Lein C., Given C., Given B., and Goddeeris J. Exploration of DSM-IV Criteria in primary care patients with medically unexplained symptoms. Psychosom Med 67 (2005) 123-129
55. Smith G., Monson R., and Ray D. Patients with multiple unexplained symptoms: Their characteristics, functional health, and health care utilization. Arch Intern Med 146 (1986) 69-72
56. Smith G., Rost K., and Kashner T. A trial of the effect of a standardized psychiatric consultation on health outcomes and costs in somaticizing patients. Arch Gen Psychiatry 52 (1995) 238-243
57. Stern R., and Fernandez M. Group cognitive and behavioral treatment for hypochondriasis. Br Med J 303 (1991) 1229-1231
58. Strassnig M., Stowell K., First M., and Pincus H. General medical and psychiatric perspectives on somatoform disorders: Separated by an uncommon language. Curr Opin Psychiatry 19 (2006) 194-200
59. Sutherland A., and Rodin G. Factitious disorders in a general hospital setting: Clinical features and a review of the literature. Psychosomatics 31 (1990) 392-399
60. Veale D. Outcome of cosmetic surgery and "DIY" surgery in patients with body dysmorphic disorder. Psychiatric Bull 24 (2000) 218-221
61. Von Korff M., Lin E., Fenton J., and Saunders K. Frequency and priority of pain patients' health care use. Clin J Pain 23 (2007) 400-408